期刊文献+

神经节苷脂GM3诱导U266细胞凋亡及作用机制研究 被引量:1

Apoptosis Effects of GM3 Ganglioside on U266 Cells and Its Possible Mechanism
下载PDF
导出
摘要 目的:探讨神经节苷脂GM3对人多发性骨髓瘤U266细胞增殖抑制和诱导凋亡的作用及其可能的作用机制。方法:MTT法和流式细胞术检测不同浓度GM3作用U266细胞48 h后细胞增殖抑制及凋亡水平;实时荧光定量PCR检测不同浓度GM3对BCL-2、BAX mRNA表达水平的影响。结果:神经节苷脂GM3可以诱导U266细胞凋亡并抑制其增殖,且随着GM3浓度增加作用增强(早期凋亡率相关系数r=0.765,P<0.05;细胞增殖抑制率相关系数r=0.899,P<0.05);与对照组比较,实验组随着GM3浓度增加,凋亡基因BAX mRNA相对表达量逐渐升高(r=0.968,P<0.05),而抗凋亡基因BCL-2 mRNA相对表达量逐渐降低(r=-0.727,P<0.05)。结论:GM3可诱导U266细胞凋亡并抑制其增殖,且具有浓度依赖性。 Objective: To investigate the proliferation-inhibitory and apoptosis-inducing effect of ganglioside GM3 on human multiple myeloma cell line U266 cells and its possible mechanisms. Methods: MTT assay and flow cytometry were used to observe the effects of GM3 ganglioside on proliferation and apoptosis of human myeloma cell line U266.Effects of different concentration of ganglioside GM3 on the mRNA expression level of BCL-2 and BAX were detected by Real-time PCR. Results: MTT assay and Flow Cytometry showed that ganglioside GM3 could induce the apoptosis and inhibit the proliferation of multiple myeloma U266 cell line,and both the effects were enhanced with the increase of GM3 ganglioside concentration. Compared with the control group,the relative expression of BAX mRNA with the increase of GM3 concentration in experimental group was enhanced gradually( r = 0. 968),while the relative mRNA expression of anti-apoptotic gene BCL-2 was decreased gradually( r =-0. 727). Conclusion: GM3 ganglioside can induce apoptosis and inhibit the proliferation of U266 cell line in a concentration dependent manner. The mechanism may be related with up-regulation of BAX expression and down-regulation of BCL-2.
作者 赵会迎 马艳萍 ZHAO Hui-Ying;MA Yan-Ping(Department of Hematology,The Second Hospital of Shanxi Medical University,Taiyuan 030001,Shansi Province,China)
出处 《中国实验血液学杂志》 CAS CSCD 北大核心 2018年第4期1022-1026,共5页 Journal of Experimental Hematology
关键词 神经节苷脂GM3 细胞凋亡 BAX BCL-2 U266细胞 GM3 ganglioside cell apoptosis BAX BCL-2 U266
  • 相关文献

参考文献5

二级参考文献34

  • 1郎丽巍,王洪允,胡蓓,江骥.多不饱和脂肪酸在癌症及炎症疾病方面的研究进展[J].中国生化药物杂志,2014,34(1):153-155. 被引量:21
  • 2佟红艳,林茂芳.5′-杂氮-2′-脱氧胞苷对高危组骨髓增生异常综合征细胞作用的体外研究[J].中国实验血液学杂志,2004,12(4):467-471. 被引量:7
  • 3谢庆祥,林吓聪,韩聪祥,赵力.Caspase-3在肾细胞癌中表达及其意义[J].中国医学工程,2005,13(5):486-488. 被引量:4
  • 4Plimack ER, Kantarjian HM, Issa JP. Decitabine and its role in the treatment of hematopoietic malignancies. Leuk Lymphoma, 2007 ; 48(8) :1472 - 1481.
  • 5Braggio E, Maiolino A, Gouveia ME, et al. Methylation status of nine tumor suppressor genes in multiple myeloma. Int J Hematol, 2010;91 ( 1 ) .87 -96.
  • 6Park G, Kang SH, Lee JH, et al. Concurrent p16 methylation pattern as an adverse prognostic factor in multiple myeloma, a methylation-specific polymerase chain reaction study using two different primer sets. Ann Hematol, 2011 ;90( 1 ) :73 -79.
  • 7Walker BA, Wardell CP, Chiecchio L, et al. Aberrant global methylation patterns affect the molecular pathogenesis and prognosis of multiple myeloma. Blood, 2011 ; 117 (2) :553 - 562.
  • 8Yuregir OO, Yurtcu E, Kizilkilic E, et al. Detecting methylation patterns of p16, MGMT, DAPK and E-cadherin genes in multiple myeloma patients. Int J Lab Hematol, 2010; 32(2) :142 -149.
  • 9Heller G, Schmidt WM, Ziegler B, et al. Genome-wide transcriptional response to 5-aza-2'-deoxycytidine and trichostatin a in multiple myeloma cells. Cancer Res ,2008 ;68 ( 1 ) :44 - 54.
  • 10Stewart D J, Issa JP, Kurzrock R, et al. Decitabine effect on tumor global DNA methylation and other parameters in a phase I trial in refractory solid tumors and lymphomas. Clin Cancer Res, 2009;15 (11) :3881 -3888.

共引文献17

同被引文献6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部